Company Filing History:
Years Active: 2021-2024
Title: David John Beech: Innovator in Medical Therapeutics
Introduction
David John Beech is a prominent inventor based in Leeds, GB. He has made significant contributions to the field of medical therapeutics, particularly in the development of innovative treatments for various health conditions. With a total of 2 patents to his name, Beech's work focuses on addressing critical health issues such as obesity and cancer.
Latest Patents
Beech's latest patents include groundbreaking research on TRPC ion channel inhibitors for therapeutic use. These inhibitors target Transient Receptor Potential Canonical (TRPC) ion channels, specifically TRPC4 and TRPC5 proteins. They are designed to combat obesity and other medical conditions, including insulin resistance associated with Type II diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, the inhibitors have potential cosmetic applications, such as promoting cosmetic weight loss. Another significant patent involves Englerin derivatives for cancer treatment. This patent discloses a compound formula aimed at treating renal cancer, along with a pharmaceutical composition and method for its application.
Career Highlights
Throughout his career, David John Beech has worked with esteemed institutions, including the University of Leeds and the National Institutes of Health, a component of the US Department of Health & Human Services. His research has been pivotal in advancing therapeutic options for patients suffering from serious health conditions.
Collaborations
Beech has collaborated with notable colleagues, including Richard James Foster and Sin Ying Cheung. These partnerships have contributed to the success and impact of his research endeavors.
Conclusion
David John Beech stands out as an influential inventor in the realm of medical therapeutics. His innovative patents and collaborations reflect his commitment to improving health outcomes through scientific research and development.